Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Seattle Genetics › Eric Sievers
ES

Eric Sievers — 16 Patents

SGSeattle Genetics: 9 patents #15 of 101Top 15%
SESeagen: 5 patents #7 of 95Top 8%
ASAres Trading S.A.: 2 patents #48 of 249Top 20%
ZYZymogenetics: 2 patents #162 of 284Top 60%
MFMayo Foundation: 1 patents #907 of 1,749Top 55%
Bothell, WA: #170 of 2,342 inventorsTop 8%
Washington: #6,223 of 76,902 inventorsTop 9%
Overall (All Time): #284,196 of 4,157,543Top 7%
16 Patents All Time
Eric Sievers has been granted 16 US patents while listed as an inventor at Seattle Genetics. The first was granted in 2010 and the most recent in January 2023. Eric Sievers ranks #284,196 of 4,157,543 US inventors in our database (top 6.8%). Patent records list Eric Sievers in Bothell, WA, US.

Patents per Year

Patents granted per year, 2010 to 2023Bar chart with a peak of 3 patents in 2021.peak 32010: 2 patents20102012: 1 patents2013: 1 patents20132014: 2 patents2015: 1 patents20152017: 1 patents2018: 1 patents20182019: 1 patents2020: 1 patents20202021: 3 patents2022: 1 patents20222023: 1 patents2023

Issued Patents All Time

Showing 1–16 of 16 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
11559558 Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conjugates Dana Kennedy 2023-01-24 $252,157,000
11369658 Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conjugates Dana Kennedy 2022-06-28 $309,040,000
11077164 Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conjugates Dana Kennedy 2021-08-03 $138,536,000
10940178 Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conjugates Dana Kennedy 2021-03-09 $291,417,000
10912813 Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conjugates Dana Kennedy 2021-02-09 $172,047,000
10722549 Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conjugates Dana Kennedy 2020-07-28 $149,413,000
10478469 Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conjugates Dana Kennedy 2019-11-19 $213,811,000
10098963 Weekly dosing regimens for anti-CD30 VC-PAB-MMAE antibody drug-conjugates Dana Kennedy 2018-10-16 $87,010,000
9713648 Weekly dosing regimens for anti-CD30 VC-PAB-MMAE antibody drug-conjugates Dana Kennedy 2017-07-25 $39,418,000
9211319 Weekly dosing regimens for anti-CD30 VC-PAB-MMAE antibody drug-conjugates Dana Kennedy, Nathan Ihle, Michael Sun 2015-12-15 $54,765,000
8808696 Methods for the treatment and prevention of abnormal cell proliferation using TACI-fusion molecules Herve Broly, Arnaud Ythier 2014-08-19
8758758 Post-relapse treatment of CD30 expressing lymphomas Dana Kennedy 2014-06-24 $44,316,000
8470329 Combination therapy with antibody-drug conjugates Ezogelin Oflazoglu, Hans-Peter Gerber 2013-06-25 $27,300,000
8263083 Combination therapy with antibody-drug conjugates Ezogelin Oflazoglu, Hans-Peter Gerber 2012-09-11 $28,977,000
7842292 Methods for treating B-cell malignancies using a TACI-Ig fusion molecule Herve Broly, Arnaud Ythier, Sharon J. Busby, Jan Ohrstrom, Ivan Nestorov +1 more 2010-11-30
7695716 Methods of treating neoplastic, autoimmune and inflammatory diseases Jonathan G. Drachman, May Kung Sutherland, Grant Risdon, Alan F. Wahl, Tim Lewis 2010-04-13 $11,681,000

Frequent Collaborators

Dana Kennedy11 shared
Herve Broly2 shared
Hans-Peter Gerber2 shared
Ezogelin Oflazoglu2 shared
Arnaud Ythier2 shared
Sharon J. Busby1 shared

Nearby-Ranked Inventors

Chung-Lin Fu16
Tyrone T. Chen16
Shivendra Katiyar16
Kevin E. Kalajan16
Henry Y. Mark16
Marco Becker16
Nak Gi Sung16
Kenta Iwai16
Brock Mammoser16